Document Detail

Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro.
MedLine Citation:
PMID:  21045015     Owner:  NLM     Status:  MEDLINE    
The chemopreventive potential of resveratrol is marred by its low bioavailability. Studies of modified resveratrol may reveal features that affect its bioefficacy and bioavailability. We compared the anti-proliferative and gene regulatory activities of resveratrol with trimethoxy-resveratrol and triacetyl-resveratrol using cultured human prostate cancer (CaP) cells. LNCaP cells were incubated with resveratrol and its analogues. Changes in proliferation, colony formation, cell cycle, apoptosis and prostate specific antigen (PSA) PSA were determined. DNA damage was assayed by phosphorylated-histone H2AX changes. Expression of total and serine-15-phosphorylated p53 and p53-inducible cell cycle regulatory protein p21 and ribonucleotide reductase subunit p53R2 involved in DNA repair were measured by immunobloting and reverse transcription-polymerase chain reaction. Exposure to resveratrol or triacetyl-resveratrol activated p53, increased p21 and p53R2 and decreased PSA expression in LNCaP cells. These changes were attenuated by the p53 inhibitor pifithrin-α. However, LNCaP cells exposed to trimethoxy-resveratrol showed induction of apoptosis, reduction in G₁ and prolongation of the SG₂M phases. Resveratrol and analogues were also studied in CWR22Rv1 (containing mutated p53) and p53-null PC-3 cells. CWR22Rv1 cells exposed to resveratrol and triacetyl-resveratrol showed a G₁S block, concomitant with increased p53 and p21 expression; however, identically treated PC-3 cells showed attenuated progression through the SG₂M phases. Trimethoxy-resveratrol did not affect CWR22Rv1 cell cycle but reduced and expanded PC-3 cells in the G₁ and SG₂M phases, respectively. These results suggest that triacetyl-resveratrol and trimethoxy-resveratrol are active against different stage CaP cells, using overlapping and distinct mechanisms.
Tze-chen Hsieh; Ying-chieh Huang; Joseph M Wu
Related Documents :
9374435 - Influence of ionizing radiation on proliferation, c-myc expression and the induction of...
20567995 - Action of sn 28049, a new dna binding topoisomerase ii-directed antitumour drug: compar...
18594935 - Brca1 185delag truncation protein, brat, amplifies caspase-mediated apoptosis in ovaria...
20178585 - Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer tr...
21509715 - Paeonol prevents excitotoxicity in rat pheochromocytoma pc12 cells via downregulation o...
22330345 - Isolation and characterization of stromal progenitor cells from ascites of patients wit...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-11-02
Journal Detail:
Title:  Carcinogenesis     Volume:  32     ISSN:  1460-2180     ISO Abbreviation:  Carcinogenesis     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-28     Completed Date:  2011-01-27     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8008055     Medline TA:  Carcinogenesis     Country:  England    
Other Details:
Languages:  eng     Pagination:  93-101     Citation Subset:  IM    
Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / pharmacology*
Blotting, Western
Cell Cycle / drug effects
Cell Line, Tumor
DNA Damage / drug effects*
DNA Repair / drug effects*
Gene Expression / drug effects*
Prostatic Neoplasms / genetics,  metabolism*
Reverse Transcriptase Polymerase Chain Reaction
Stilbenes / pharmacology*
Reg. No./Substance:
0/Antineoplastic Agents; 0/Stilbenes; Q369O8926L/resveratrol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inpatients are sicker than outpatients; finally it's evidence-based.
Next Document:  Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteina...